These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7500273)

  • 1. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin.
    Oldenburg KR; Vo KT; Smith GA; Selick HE
    J Pharm Sci; 1995 Aug; 84(8):915-21. PubMed ID: 7500273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iontophoretic delivery of a telomeric oligonucleotide.
    Brand RM; Iversen PL
    Pharm Res; 1996 Jun; 13(6):851-4. PubMed ID: 8792421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of size and sequence on the iontophoretic delivery of oligonucleotides.
    Brand RM; Wahl A; Iversen PL
    J Pharm Sci; 1998 Jan; 87(1):49-52. PubMed ID: 9452967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iontophoresis of bases, nucleosides, and nucleotides.
    van der Geest R; Hueber F; Szoka FC; Guy RH
    Pharm Res; 1996 Apr; 13(4):553-8. PubMed ID: 8710745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin.
    Al-Khalili M; Meidan VM; Michniak BB
    AAPS PharmSci; 2003; 5(2):E14. PubMed ID: 12866941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iontophoretic transdermal delivery of haloperidol.
    Alvarez-Figueroa MJ; Araya-Silva I; Díaz-Tobar C
    Pharm Dev Technol; 2006; 11(3):371-5. PubMed ID: 16895847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal delivery of antisense oligonucleotides by the pulse depolarization iontophoretic system.
    Aramaki Y; Arima H; Takahashi M; Miyazaki E; Sakamoto T; Tsuchiya S
    Biol Pharm Bull; 2003 Oct; 26(10):1461-6. PubMed ID: 14519955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
    Dubey S; Kalia YN
    J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential use of iontophoresis for transdermal delivery of NF-kappaB decoy oligonucleotides.
    Hashim II; Motoyama K; Abd-Elgawad AE; El-Shabouri MH; Borg TM; Arima H
    Int J Pharm; 2010 Jun; 393(1-2):127-34. PubMed ID: 20417264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An experimental model for interpreting percutaneous penetration of oligonucleotides that incorporates the role of keratinocytes.
    Brand RM; Haase K; Hannah TL; Iversen PL
    J Invest Dermatol; 1998 Dec; 111(6):1166-71. PubMed ID: 9856834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.
    Kumar MG; Lin S
    Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of iontophoretic parameters for the transdermal delivery of methotrexate.
    Vemulapalli V; Banga AK; Friden PM
    Drug Deliv; 2008 Sep; 15(7):437-42. PubMed ID: 18712621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irontophoresis: transdermal delivery of iron by iontophoresis.
    Murthy SN; Vaka SR
    J Pharm Sci; 2009 Aug; 98(8):2670-6. PubMed ID: 19117049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameters controlling topical delivery of oligonucleotides by electroporation.
    Regnier V; Le Doan T; Préat V
    J Drug Target; 1998; 5(4):275-89. PubMed ID: 9713977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal iontophoretic drug delivery: advances and challenges.
    Ita K
    J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
    Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
    Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iontophoretic drug delivery.
    Kalia YN; Naik A; Garrison J; Guy RH
    Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal iontophoresis of insulin: III. Influence of electronic parameters.
    Pillai O; Kumar N; Dey CS; Borkute ; Sivaprasad N; Panchagnula R
    Methods Find Exp Clin Pharmacol; 2004; 26(6):399-408. PubMed ID: 15349135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.